Inflammation-specific TX imaging using anti-intercellular adhesion molecule 1 antibody-conjugated gadolinium diethylenetriaminepentaacetic acid

Molecular Imaging

Volumn 6, Issue 2, 2007, Pages 75-84

  Choi, Kyu Sil ^a   Kim, Sun Hee ^a   Cai, Quan Yu ^a   Kim, Soo Yeon ^a   Kim, Hyang Ok ^a   Lee, Hye Jin ^a   Kim, Eun A ^a   Yoon, Seong Eon ^a   Yun, Ki Jung ^a   Yoon, Kwon Ha ^a  

^a Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; ANTIBODIES; CELLS; FLAMMABILITY; GADOLINIUM; TISSUE;

BIOCONJUGATION; COMMON SYMPTOM; DIETHYLENETRIAMINEPENTAACETIC ACID; INFLAMMATORY TISSUE;

IMAGING TECHNIQUES;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY;

ABSCESS; ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DISEASE MODEL; ENDOTHELIUM CELL; HALF LIFE TIME; IMMUNOHISTOCHEMISTRY; INFLAMMATION; METHODOLOGY; MICROBIOLOGY; MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; STAPHYLOCOCCUS AUREUS;

ABSCESS; ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GADOLINIUM DTPA; HALF-LIFE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; MAGNETIC RESONANCE IMAGING; MICE; RATS; STAPHYLOCOCCUS AUREUS;

EID: 34250717377     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2007.00005     Document Type: Article

References (34)

1. Aime S, Barge A, Cabella C, et al. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr Pharm Biotechnol 2004;5:509-18.
2. Merbach AE, Toth E. The chemistry of contrast agents in medical magnetic resonance imaging. New York: Wiley; 2001.
3. Paschkunova-Martic I, Kremser C, Mistlberger K, et al. Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI) Histochem Cell Biol 2005;123:283-301.
4. Morawski AM, Lanza GA, Wickline SA. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005;16:89-92.
5. Delikatny EJ, Poptani H. MR techniques for in vivo molecular and cellular imaging. Radiol Clin North Am 2005;43:205-20.
6. Aime S, Barge A, Gianolio E, et al. High relaxivity contrast agents for MRI and molecular imaging. Ernst Schering Res Found Workshop 2005;49:99-121.
7. Allen MJ, Meade TJ, Magnetic resonance contrast agents for medical and molecular imaging. Met Ions Biol Syst 2004;42:1-38.
8. Laurent S, Botteman F, Vander EL, Muller RN. Optimising the design of paramagnetic MRI contrast agents: influence of backbone substitution on the water exchange rate of Gd-DTPA derivatives. MAGMA 2004;16:235-45.
9. Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 2003; 63:2723-7.
10. Poduslo JF, Curran GL, Peterson JA, et al. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques. Biochemistry 2004;43:6064-75.
11. Tung CH, Ho NH, Zeng Q, et al. Novel factor XIII probes for blood coagulation imaging. Chembiochemistry 2003;4:897-9.
12. Botnar RM, Perez AS, Witte S, et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004; 109:2023-9.
13. Aime S, Barge A, Cabella C, et al. Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates. Curr Pharm Biotechnol 2004;5:509-18.
14. Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/ inflammation in the new millennium. Eur J Nucl Med 2001;28:241-52.
15. Beltran J. MR imaging of soft-tissue infection. Magn Reson Imaging Clin N Am 1995;3:743-51.
16. Mergo PJ, Ros PR. MR imaging of inflammatory disease of the liver. Magn Reson Imaging Clin N Am 1997;5:367-76.
17. Nunn AD, Linder KE, Tweedle MF. Can receptors be imaged with MRI agents? Q J Nucl Med 1997;41:155-62.
18. Hopkins AM, Baird AW, Nusrat A. ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv Drug Deliv Rev 2004;56:763-78.
19. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
20. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-12.
21. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.
22. Eksteen B, Walker LS, Adams DH. Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease. Gut 2005;54:4-6.
23. Sligh JE Jr, Ballantyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1993;90: 8529-33.
24. Barber PA, Foniok T, Kirk D, et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 2004;56:116-20.
25. Bogdanov A Jr, Matuszewski L, Bremer C, et al. Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecular targets. Mol Imaging 2002;1:16-23.
26. Lanza GM, Winter PM, Caruthers SD, et al. Magnetic resonance molecular imaging with nanopartides. I Nucl Cardiol 2004;11:733-43.
27. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 2004;17:484-99.
28. Morawski AM, Winter PM, Crowder KC, et al. Targeted nanopartides for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;51:480-6.
29. Brasch R, Pham C, Shames O, et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media. J Magn Reson Imaging 1997;7:68-74.
30. Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 2003; 63:2723-7.
31. Gohr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J. The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging. Invest Radiol 1993;28:789-95.
32. Artemov D, Bhujwalla ZM, Bulte JW. Magnetic resonance imaging of cell surface receptors using targeted contrast agents. Curr Pharm Biotechnol 2004;5:485-94.
33. Sato N, Kobayashi H, Hiraga A, et al. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 2001;46:1169-73.
34. Bremer C, Bankert J, Filler T, et al. High-dose Gd-DTPA vs. Bis-Gd-mesoporphyrin for monitoring laser-induced tissue necrosis. J Magn Reson Imaging 2005;21:801-8.